WPE_6899_460x337.jpg

Onkologie

Sie befinden sich hier:

Onkologie

Autor Titel/Link Jahr Journal
Dienstmann et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. 2017 Nature reviews. Cancer
Galluzzi et al. Immunogenic cell death in cancer and infectious disease. 2017 Nature reviews. Immunology
Inadomi Screening for Colorectal Neoplasia. 2017 The New England journal of medicine
Thiele et al. Circulating Tumor Cells: Fluid Surrogates of Solid Tumors. 2017 Annual review of pathology
Attard et al. Prostate cancer. 2016 Lancet
Bracken et al. A network-biology perspective of microRNA function and dysfunction in cancer. 2016 Nature reviews. Genetics
Cabanillas et al. Thyroid cancer. 2016 Lancet (London, England)
Capitanio and Montorsi Renal cancer. 2016 Lancet
Dalerba et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. 2016 N Engl J Med
Deng et al. Obesity, Inflammation, and Cancer. 2016 Annu Rev Pathol
Elgui de Oliveira et al. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. 2016 Trends in microbiology
Feinberg et al. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. 2016 Nat Rev Genet
Foulkes et al. Population genetic testing for cancer susceptibility: founder mutations to genomes. 2016 Nat Rev Clin Oncol
Gabriel et al. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. 2016 Clin Chem
Gibney et al. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. 2016 The Lancet. Oncology
Haji-Ghassemi et al. Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin. 2016 The Journal of biological chemistry
Hiley et al. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease. 2016 Lancet (London, England)
Hopkins et al. Obesity and Cancer Mechanisms: Cancer Metabolism. 2016 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Ifa and Eberlin Ambient Ionization Mass Spectrometry for Cancer Diagnosis and Surgical Margin Evaluation. 2016 Clin Chem
Iyengar et al. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. 2016 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Joerger and Fersht The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches. 2016 Annu Rev Biochem
Kalluri The biology and function of fibroblasts in cancer. 2016 Nature reviews. Cancer
Kamat et al. Bladder cancer. 2016 Lancet (London, England)
Kamisawa et al. Pancreatic cancer. 2016 Lancet (London, England)
Khalil et al. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. 2016 Nat Rev Clin Oncol
León-Mateos et al. Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back. 2016 International journal of molecular sciences
Macintyre et al. Sequencing Structural Variants in Cancer for Precision Therapeutics. 2016 Trends in genetics : TIG
Matin et al. MicroRNA Theranostics in Prostate Cancer Precision Medicine. 2016 Clinical chemistry
Mayne et al. Diet, nutrition, and cancer: past, present and future. 2016 Nature reviews. Clinical oncology
Morice et al. Endometrial cancer. 2016 Lancet
Nagrath et al. Opportunities and Challenges for Pancreatic Circulating Tumor Cells. 2016 Gastroenterology
Ng Iron, microbiota and colorectal cancer 2016 Wiener Medizinische Wochenschrift
Oude Munnink et al. Therapeutic drug monitoring of monoclonal antibodies in inflammatory and malignant disease: Translating TNF-α experience to oncology. 2016 Clin Pharmacol Ther
Pantel and Alix-Panabières Functional Studies on Viable Circulating Tumor Cells. 2016 Clin Chem
Parker et al. Antitumour actions of interferons: implications for cancer therapy. 2016 Nat Rev Cancer
Rajpert-De Meyts et al. Testicular germ cell tumours. 2016 Lancet
Räsänen et al. Emerging Roles of SPINK1 in Cancer. 2016 Clin Chem
Roos et al. DNA damage and the balance between survival and death in cancer biology. 2016 Nat Rev Cancer
Sauzay et al. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. 2016 Clinica chimica acta; international journal of clinical chemistry
Shieh et al. Population-based screening for cancer: hope and hype. 2016 Nature reviews. Clinical oncology
Steeg Targeting metastasis. 2016 Nat Rev Cancer
Strum Colorectal Adenomas. 2016 N Engl J Med
Sur and Taipale The role of enhancers in cancer. 2016 Nature reviews. Cancer
Swanton and Govindan Clinical Implications of Genomic Discoveries in Lung Cancer. 2016 N Engl J Med
Tie and Gibbs Sequencing Circulating Cell-Free DNA: The Potential to Refine Precision Cancer Medicine. 2016 Clin Chem
Topalian et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. 2016 Nat Rev Cancer
Truitt and Ruggero New frontiers in translational control of the cancer genome. 2016 Nat Rev Cancer
Vargas and Harris Biomarker development in the precision medicine era: lung cancer as a case study. 2016 Nature reviews. Cancer
Xu et al. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. 2016 Critical reviews in clinical laboratory sciences
Zhang et al. Interleukin-10: An Immune-Activating Cytokine in Cancer Immunotherapy. 2016 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Zhang et al. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. 2016 International journal of laboratory hematology
Zhou et al. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma. 2016 Journal of gastrointestinal cancer
Zhou et al. Cytokine Signaling in Skeletal Muscle Wasting. 2016 Trends Endocrinol Metab
Zijlstra and Stoorvogel Prostasomes as a source of diagnostic biomarkers for prostate cancer. 2016 The Journal of clinical investigation
Aggarwal et al. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population. 2015 Clin Chim Acta
Barber STING: infection, inflammation and cancer. 2015 Nat Rev Immunol
Baron et al. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. 2015 N Engl J Med
Chalkiadaki and Guarente The multifaceted functions of sirtuins in cancer. 2015 Nat Rev Cancer
Crusz and Balkwill Inflammation and cancer: advances and new agents. 2015 Nat Rev Clin Oncol
Di Noto et al. Polyclonal versus monoclonal immunoglobulin-free light chains quantification. 2015 Annals of clinical biochemistry
Ettl Genexpressionstests zur Prognose und Prädiktion 2015 Der Gynäkologe
Ferraro et al. Human epididymis protein 4: factors of variation. 2015 Clin Chim Acta
Filella and Foj Emerging biomarkers in the detection and prognosis of prostate cancer. 2015 Clin Chem Lab Med
Friedman et al. Precision medicine for cancer with next-generation functional diagnostics. 2015 Nat Rev Cancer
Hagerling et al. Balancing the innate immune system in tumor development. 2015 Trends Cell Biol
He et al. Current State of Circulating MicroRNAs as Cancer Biomarkers. 2015 Clin Chem
Jiang et al. Autophagy in cellular metabolism and cancer. 2015 J Clin Invest
Khanmi et al. MicroRNA in prostate cancer. 2015 Clin Chim Acta
Lieben Diagnosis: RNA-seq for blood-based pan-cancer diagnostics. 2015 Nat Rev Cancer
Lowry et al. The Role of Exosomes in Breast Cancer. 2015 Clin Chem
Michel et al. Molekulare Tumortherapie 2015 Internist (Berl)
Neal et al. Developing biomarker-specific end points in lung cancer clinical trials. 2015 Nat Rev Clin Oncol
Nordgren and Skildum The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer. 2015 Eur J Clin Invest
O'Hare et al. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity. 2015 Expert Rev Cardiovasc Ther
Pinho and Reis Glycosylation in cancer: mechanisms and clinical implications. 2015 Nat Rev Cancer
Robson et al. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. 2015 J Clin Oncol
Sanguedolce et al. Molecular markers in bladder cancer: Novel research frontiers. 2015 Crit Rev Clin Lab Sci
Schwaederle et al. Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. 2015 J Clin Oncol
Seifert et al. Screening für Krebserkrankungen 2015 Internist (Berl)
Shalapour and Karin Immunity, inflammation, and cancer: an eternal fight between good and evil. 2015 J Clin Invest
Stoffel Screening in GI Cancers: The Role of Genetics. 2015 J Clin Oncol
Stowell et al. Protein glycosylation in cancer. 2015 Annu Rev Pathol
Sundaresan and Haber Does molecular monitoring matter in early-stage breast cancer? 2015 Sci Transl Med
Tie et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. 2015 Ann Oncol
Van Poznak et al. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. 2015 J Clin Oncol
West et al. Emerging cytokine networks in colorectal cancer. 2015 Nat Rev Immunol
White The role for autophagy in cancer. 2015 J Clin Invest
Young and Quirke Secrets from the microbiome: molecular biology meets microbiology meets histopathology...meets clinical biochemistry. 2015 Annals of clinical biochemistry